Insider Monitor Realtime Top 10
  1. Company List - H
  2. HOLX

Insider Trading activities at Hologic Inc (HOLX)

Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Hologic Inc (HOLX) since 2006 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Hologic Inc. Table 2 shows the detailed insider transactions. This company's CIK number is 859737.

Total stock buying since 2006: $12,244,759.
Total stock sales since 2006: $634,825,850.
Total stock option exercises since 2006: $159,732,670.


 1   2   3   4   5 
51 insiders reported insider trading activities at Hologic Inc (HOLX):
▪ Insider trading activities of Griffin John M.
▪ Insider trading activities of Icahn Partners Master Fund Lp
▪ Insider trading activities of Garrett Scott T
▪ Insider trading activities of Cohn Benjamin Jordan
▪ Insider trading activities of Williamson Steve S
▪ Insider trading activities of Mitchell Essex D
▪ Insider trading activities of Bebo Allison P
▪ Insider trading activities of Mills Roger D.
▪ Insider trading activities of Nawana Namal
▪ Insider trading activities of Lerner Arthur G
▪ Insider trading activities of Wendell Amy Mcbride
▪ Insider trading activities of Schnittker Brandon
▪ Insider trading activities of Hastie Rohan
▪ Insider trading activities of Dockendorff Charles J
▪ Insider trading activities of Compton Eric B.
▪ Insider trading activities of Kingsley Stuart A
▪ Insider trading activities of Brady David J
▪ Insider trading activities of Mcmahon Robert W.
▪ Insider trading activities of Casey Mark J
▪ Insider trading activities of Lavance David R Jr
▪ Insider trading activities of Thornal Kevin R
▪ Insider trading activities of Levangie Daniel J
▪ Insider trading activities of Muir Glenn P
▪ Insider trading activities of West Thomas A.
▪ Insider trading activities of Sullivan Patrick J
▪ Insider trading activities of Jacobs Irwin
▪ Insider trading activities of Lavallee Robert H
▪ Insider trading activities of Valenti Peter J. Iii
▪ Insider trading activities of Doran Howard Jr
▪ Insider trading activities of Merksamer Samuel J.
▪ Insider trading activities of Coughlin Christopher J
▪ Insider trading activities of Soltani Peter
▪ Insider trading activities of Levy Lawrence M
▪ Insider trading activities of Egstrand Claus
▪ Insider trading activities of Pekarsky John R
▪ Insider trading activities of Cascella Robert
▪ Insider trading activities of Oberton Karleen Marie
▪ Insider trading activities of Ullian Elaine
▪ Insider trading activities of Daugherty Sean S.
▪ Insider trading activities of Crawford Sally
▪ Insider trading activities of Cumming John W
▪ Insider trading activities of Macmillan Stephen P
▪ Insider trading activities of Christodoro Jonathan
▪ Insider trading activities of Harding David
▪ Insider trading activities of Stamoulis Christiana
▪ Insider trading activities of Leaming Nancy
▪ Insider trading activities of Fajardo Laurie
▪ Insider trading activities of Madaus Martin D
▪ Insider trading activities of Mcdaniel C William
▪ Insider trading activities of Wilson Wayne
▪ Insider trading activities of Stein Jay A

Table 1. Yearly summary of insider stock purchases, sales, and option exercises at Hologic Inc (HOLX).
Insider Buying Insider Sales Option Exercises
Year Shares Value Shares Value Shares Value
2025 5,445 $300,760 0 $0 0 $0
2024 0 $0 85,021 $6,531,480 61,093 $2,390,035
2023 0 $0 86,729 $6,360,996 56,839 $1,624,479
2022 0 $0 95,152 $7,208,083 75,268 $3,063,376
2021 0 $0 52,750 $4,080,776 40,079 $1,528,052
2020 0 $0 588,098 $32,171,174 640,144 $15,453,293
2019 0 $0 445,566 $21,146,042 482,355 $10,630,524
2018 24,800 $954,245 117,125 $4,815,729 153,020 $1,605,390
2017 0 $0 288,613 $12,275,775 1,264,869 $10,224,820
2016 0 $0 142,483 $5,376,337 695,535 $3,580,480
2015 0 $0 6,478,040 $261,377,816 784,479 $16,968,532
2014 246,195 $5,187,797 508,074 $11,710,696 608,732 $10,140,717
2013 0 $0 721,384 $15,767,950 691,566 $6,338,665
2012 0 $0 671,295 $13,318,481 648,806 $4,901,686
2011 0 $0 1,109,135 $22,934,215 512,871 $5,091,350
2010 0 $0 48,420 $812,180 26,953 $372,668
2009 7,500 $92,571 542,500 $8,297,005 672,500 $3,253,657
2008 282,005 $5,705,164 62,960 $4,398,669 115,792 $2,084,577
2007 67 $4,222 2,840,654 $175,681,533 2,706,780 $57,736,860
2006 0 $0 423,000 $20,560,913 427,000 $2,743,509

Table 2. Monthly summary of insider trading at Hologic Inc (HOLX).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2025-05 5,445 $300,760 0 $0 0 $0
2024-12 0 $0 24,856 $1,897,482 22,902 $1,294,306
2024-08 0 $0 5,569 $457,128 0 $0
2024-07 0 $0 12,711 $1,012,822 12,711 $337,945
2024-03 0 $0 26,945 $2,043,548 25,480 $757,784
2024-01 0 $0 14,940 $1,120,500 0 $0
2023-12 0 $0 10,000 $687,120 0 $0
2023-11 0 $0 55,211 $3,898,078 47,711 $1,250,505
2023-06 0 $0 10,000 $797,240 0 $0
2023-05 0 $0 2,390 $200,114 0 $0
2023-02 0 $0 9,128 $778,444 9,128 $373,974
2022-11 0 $0 84,256 $6,372,984 64,372 $2,629,594
2022-05 0 $0 10,896 $835,099 10,896 $433,782
2021-11 0 $0 2,570 $194,790 0 $0
2021-08 0 $0 31,683 $2,405,193 31,683 $1,192,548
2021-05 0 $0 4,001 $260,149 0 $0
2021-02 0 $0 14,496 $1,220,644 8,396 $335,504
2020-12 0 $0 18,346 $1,356,979 16,869 $654,517
2020-11 0 $0 45,588 $3,277,166 56,734 $1,715,825
2020-09 0 $0 15,000 $937,500 20,461 $536,282
2020-08 0 $0 4,924 $350,785 2,986 $71,126
2020-06 0 $0 10,493 $567,356 10,493 $275,021
2020-05 0 $0 247,327 $12,655,541 264,581 $5,943,106
2020-04 0 $0 4,906 $245,300 4,906 $158,856

Table 3. Detailed insider trading at Hologic Inc (HOLX)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2025-05-07 Madaus Martin D (Director) Buy 5,445 55.24 300,760
2024-12-04 Mitchell Essex D (Chief Operating Officer) Sale 24,856 76.34 1,897,482
2024-12-04 Mitchell Essex D (Chief Operating Officer) Option Ex 22,902 56.52 1,294,306
2024-08-06 Schnittker Brandon (Div. President, GYN Surgical) Sale 476 83.11 39,559
2024-08-01 Cohn Benjamin Jordan (Principal Accounting Officer) Sale 5,093 81.99 417,569
2024-07-17 Stamoulis Christiana (Director) Sale 9,039 79.50 718,600
2024-07-17 Stamoulis Christiana (Director) Option Ex 9,039 26.74 241,702
2024-07-17 Macmillan Stephen P (Chairman, President and CEO) Sale 3,672 80.13 294,222
2024-07-17 Macmillan Stephen P (Chairman, President and CEO) Option Ex 3,672 26.21 96,243
2024-03-14 Garrett Scott T (Director) Sale 16,441 75.50 1,241,295
2024-03-14 Garrett Scott T (Director) Option Ex 16,441 31.39 516,082
2024-03-08 Dockendorff Charles J (Director) Sale 1,465 76.21 111,647
2024-03-08 Crawford Sally (Director) Sale 9,039 76.40 690,606
2024-03-08 Crawford Sally (Director) Option Ex 9,039 26.74 241,702
2024-01-29 Oberton Karleen Marie (Chief Financial Officer) Sale 14,940 75.00 1,120,500
2023-12-11 Garrett Scott T (Director) Sale 10,000 68.71 687,120
2023-11-29 Macmillan Stephen P (Chairman, President and CEO) Sale 47,711 70.41 3,359,188
2023-11-29 Macmillan Stephen P (Chairman, President and CEO) Option Ex 47,711 26.21 1,250,505
2023-11-21 Mitchell Essex D (Div. President, GYN Surgical) Sale 7,500 71.85 538,890
2023-06-15 Garrett Scott T (Director) Sale 10,000 79.72 797,240
2023-05-05 Mitchell Essex D (Div. President, GYN Surgical) Sale 2,390 83.73 200,114
2023-02-07 Cohn Benjamin Jordan (Principal Accounting Officer) Sale 9,128 85.28 778,444
2023-02-07 Cohn Benjamin Jordan (Principal Accounting Officer) Option Ex 9,128 40.97 373,974
2022-11-15 Thornal Kevin R (Group Pres, Global Diagnostics) Sale 38,236 75.34 2,880,546
2022-11-15 Thornal Kevin R (Group Pres, Global Diagnostics) Option Ex 24,980 40.85 1,020,432
2022-11-14 Griffin John M. (General Counsel) Sale 26,902 76.28 2,052,165
2022-11-14 Griffin John M. (General Counsel) Option Ex 26,902 40.85 1,098,946
2022-05-17 Cohn Benjamin Jordan (Principal Accounting Officer) Sale 3,844 78.75 302,730
2022-05-17 Cohn Benjamin Jordan (Principal Accounting Officer) Option Ex 3,844 40.85 157,027
2022-05-13 Cohn Benjamin Jordan (Principal Accounting Officer) Sale 7,052 75.49 532,369
2022-05-13 Cohn Benjamin Jordan (Principal Accounting Officer) Option Ex 7,052 39.24 276,755
2021-11-19 Cohn Benjamin Jordan (Principal Accounting Officer) Sale 2,570 75.79 194,790
2021-08-10 Cohn Benjamin Jordan (Principal Accounting Officer) Sale 5,000 77.48 387,425
2021-08-10 Cohn Benjamin Jordan (Principal Accounting Officer) Option Ex 5,000 37.64 188,200
2021-08-09 Griffin John M. (General Counsel) Sale 26,683 75.62 2,017,768
2021-08-09 Griffin John M. (General Counsel) Option Ex 26,683 37.64 1,004,348
2021-05-10 Daugherty Sean S. (Group President, BSH & Surg.) Sale 4,001 65.02 260,149
2021-02-05 Bebo Allison P (SVP, Human Resources) Sale 6,100 84.06 512,778
2021-02-04 Cohn Benjamin Jordan (Principal Accounting Officer) Sale 8,396 84.31 707,866
2021-02-04 Cohn Benjamin Jordan (Principal Accounting Officer) Option Ex 8,396 39.96 335,504
2020-12-10 Thornal Kevin R (Div. President, Diagnostics) Sale 16,869 74.00 1,248,221
2020-12-10 Thornal Kevin R (Div. President, Diagnostics) Option Ex 16,869 38.80 654,517
2020-12-10 Cohn Benjamin Jordan (Principal Accounting Officer) Sale 1,477 73.64 108,758
2020-11-18 Griffin John M. (General Counsel) Sale 22,900 71.08 1,627,617
2020-11-18 Griffin John M. (General Counsel) Option Ex 22,900 39.96 915,084
2020-11-17 Cohn Benjamin Jordan (Principal Accounting Officer) Sale 5,000 72.58 362,900
2020-11-17 Cohn Benjamin Jordan (Principal Accounting Officer) Option Ex 5,000 26.21 131,050
2020-11-12 Cohn Benjamin Jordan (Principal Accounting Officer) Sale 6,542 70.60 461,845
2020-11-12 Cohn Benjamin Jordan (Principal Accounting Officer) Option Ex 6,542 26.21 171,465
2020-11-09 Garrett Scott T (Director) Option Ex 11,146 22.35 249,113
2020-11-04 Stamoulis Christiana (Director) Sale 11,146 74.00 824,804
2020-11-04 Stamoulis Christiana (Director) Option Ex 11,146 22.35 249,113
2020-09-22 Oberton Karleen Marie (Chief Financial Officer) Option Ex 5,461 26.21 143,132
2020-09-21 Oberton Karleen Marie (Chief Financial Officer) Sale 15,000 62.50 937,500
2020-09-21 Oberton Karleen Marie (Chief Financial Officer) Option Ex 15,000 26.21 393,150
2020-08-03 Cohn Benjamin Jordan (Principal Accounting Officer) Sale 4,924 71.24 350,785
2020-08-03 Cohn Benjamin Jordan (Principal Accounting Officer) Option Ex 2,986 23.82 71,126
2020-06-30 Valenti Peter J. Iii (Division Pres., Breast Health) Sale 10,493 54.07 567,356
2020-06-30 Valenti Peter J. Iii (Division Pres., Breast Health) Option Ex 10,493 26.21 275,021
2020-05-22 Valenti Peter J. Iii (Division Pres., Breast Health) Sale 10,493 51.82 543,778
2020-05-22 Valenti Peter J. Iii (Division Pres., Breast Health) Option Ex 10,493 26.21 275,021
2020-05-22 Crawford Sally (Director) Sale 31,950 51.99 1,661,080
2020-05-15 Thornal Kevin R (Div. President, Diagnostics) Sale 13,888 51.51 715,426
2020-05-15 Thornal Kevin R (Div. President, Diagnostics) Option Ex 13,888 26.01 361,226
2020-05-13 Macmillan Stephen P (Chairman, President and CEO) Sale 190,996 50.97 9,735,257
2020-05-13 Macmillan Stephen P (Chairman, President and CEO) Option Ex 215,996 22.29 4,814,550
2020-05-01 Garrett Scott T (Director) Option Ex 24,204 20.34 492,309
2020-04-28 Griffin John M. (General Counsel) Sale 4,906 50.00 245,300
2020-04-28 Griffin John M. (General Counsel) Option Ex 4,906 32.38 158,856
2020-03-09 Crawford Sally (Director) Sale 11,146 43.93 489,677
2020-03-09 Crawford Sally (Director) Option Ex 11,146 22.35 249,113
2020-02-03 Macmillan Stephen P (Chairman, President and CEO) Sale 194,396 53.54 10,407,184
2020-02-03 Macmillan Stephen P (Chairman, President and CEO) Option Ex 215,996 22.29 4,814,550
2020-01-13 Griffin John M. (General Counsel) Sale 19,624 52.87 1,037,579
2020-01-13 Griffin John M. (General Counsel) Option Ex 19,624 33.88 664,861
2020-01-02 Oberton Karleen Marie (Chief Financial Officer) Sale 16,348 51.76 846,107
2020-01-02 Oberton Karleen Marie (Chief Financial Officer) Option Ex 16,348 22.64 370,036
2019-12-04 Cohn Benjamin Jordan (Principal Accounting Officer) Sale 4,379 52.12 228,224
2019-12-04 Cohn Benjamin Jordan (Principal Accounting Officer) Option Ex 4,379 21.45 93,929
2019-11-22 Cohn Benjamin Jordan (Principal Accounting Officer) Sale 4,400 50.09 220,400
2019-11-22 Cohn Benjamin Jordan (Principal Accounting Officer) Option Ex 4,400 21.45 94,380
2019-11-22 Stamoulis Christiana (Director) Sale 12,306 49.75 612,223
2019-11-22 Stamoulis Christiana (Director) Option Ex 12,306 20.01 246,243
2019-11-11 Macmillan Stephen P (Chairman, President and CEO) Sale 194,396 45.80 8,903,531
2019-11-11 Macmillan Stephen P (Chairman, President and CEO) Option Ex 215,996 22.29 4,814,550
2019-09-03 Valenti Peter J. Iii (Division Pres., Breast Health) Sale 7,766 49.14 381,621
2019-09-03 Valenti Peter J. Iii (Division Pres., Breast Health) Option Ex 7,766 23.82 184,986
2019-08-05 Macmillan Stephen P (Chairman, President and CEO) Sale 194,396 48.84 9,493,911
2019-08-05 Macmillan Stephen P (Chairman, President and CEO) Option Ex 215,996 22.29 4,814,550
2019-06-03 Valenti Peter J. Iii (Division Pres., Breast Health) Sale 4,545 44.07 200,298
2019-03-18 Crawford Sally (Director) Sale 12,306 47.61 585,888
2019-03-18 Crawford Sally (Director) Option Ex 12,306 20.01 246,243
2019-03-11 Cohn Benjamin Jordan (Principal Accounting Officer) Sale 6,830 46.70 318,961
2019-03-11 Cohn Benjamin Jordan (Principal Accounting Officer) Option Ex 6,830 19.86 135,643
2019-03-01 Valenti Peter J. Iii (Division Pres., Breast Health) Sale 4,242 47.38 200,985
2019-02-02 Griffin John M. (General Counsel) Option Ex 2,376 .00 0
2018-12-07 Valenti Peter J. Iii (Division Pres., Breast Health) Sale 4,740 42.20 200,028
2018-11-30 Cohn Benjamin Jordan (Principal Accounting Officer) Sale 10,000 44.49 444,870
2018-11-30 Cohn Benjamin Jordan (Principal Accounting Officer) Option Ex 10,000 19.86 198,600
2018-11-28 Stamoulis Christiana (Director) Sale 13,257 44.50 589,949
2018-11-28 Stamoulis Christiana (Director) Option Ex 13,257 17.51 232,130
2018-11-16 Bebo Allison P (SVP, Human Resources) Sale 6,500 42.00 273,000
2018-11-08 Oberton Karleen Marie (Chief Financial Officer) Sale 1,312 41.90 54,972
2018-11-07 Valenti Peter J. Iii (Division Pres., Breast Health) Option Ex 1,908 .00 0
2018-11-07 Oberton Karleen Marie (Chief Financial Officer) Sale 3,806 40.83 155,398
2018-11-07 Oberton Karleen Marie (Chief Financial Officer) Option Ex 1,860 .00 0
2018-11-07 Macmillan Stephen P (Chairman, President and CEO) Option Ex 17,348 .00 0
2018-11-06 Oberton Karleen Marie (Chief Financial Officer) Sale 546 39.96 21,818
2018-11-05 Griffin John M. (General Counsel) Option Ex 2,503 .00 0
2018-11-05 West Thomas A. (Div President & GM, Diagnostic) Option Ex 2,086 .00 0
2018-11-05 Valenti Peter J. Iii (Division Pres., Breast Health) Option Ex 2,086 .00 0
2018-11-05 Oberton Karleen Marie (Chief Financial Officer) Option Ex 775 .00 0
2018-11-05 Macmillan Stephen P (Chairman, President and CEO) Option Ex 15,119 .00 0
2018-10-03 West Thomas A. (Div President & GM, Diagnostic) Option Ex 4,064 .00 0
2018-10-02 Stamoulis Christiana (Director) Sale 30,967 40.70 1,260,480
2018-10-02 Stamoulis Christiana (Director) Option Ex 30,967 15.29 473,485
2018-09-19 Cohn Benjamin Jordan (Principal Accounting Officer) Sale 3,437 41.50 142,635
2018-09-19 Cohn Benjamin Jordan (Principal Accounting Officer) Option Ex 3,437 17.09 58,738
2018-09-17 Crawford Sally (Director) Sale 13,257 39.54 524,168
2018-09-17 Crawford Sally (Director) Option Ex 13,257 17.51 232,130
2018-05-29 Valenti Peter J. Iii (Division Pres., Breast Health) Sale 10,107 38.52 389,321
2018-05-29 Valenti Peter J. Iii (Division Pres., Breast Health) Option Ex 7,766 23.82 184,986
2018-05-26 Mcmahon Robert W. (Chief Financial Officer) Option Ex 7,347 .00 0
2018-05-25 Valenti Peter J. Iii (Division Pres., Breast Health) Option Ex 3,411 .00 0
2018-05-25 Oberton Karleen Marie (Corp. VP & Chief Acctg Officer) Option Ex 525 .00 0
2018-05-02 Oberton Karleen Marie (Corp. VP & Chief Acctg Officer) Sale 12,196 40.00 487,840
2018-05-02 Oberton Karleen Marie (Corp. VP & Chief Acctg Officer) Option Ex 12,196 18.48 225,321
2018-03-16 Bebo Allison P (SVP, Human Resources) Sale 7,000 38.75 271,250
2018-03-15 Dockendorff Charles J (Director) Buy 13,000 38.80 504,399
2018-03-14 Wendell Amy Mcbride (Director) Buy 5,200 38.43 199,825
2018-03-07 Mcmahon Robert W. (Chief Financial Officer) Option Ex 732 .00 0
2018-02-13 Nawana Namal (Director) Buy 6,600 37.88 250,021
2018-02-02 Griffin John M. (General Counsel) Option Ex 2,376 .00 0
2017-12-06 Macmillan Stephen P (Chairman, President and CEO) Option Ex 47,668 .00 0
2017-11-20 Oberton Karleen Marie (Corp. VP & Chief Acctg Officer) Sale 1,023 39.84 40,756
2017-11-18 Oberton Karleen Marie (Corp. VP & Chief Acctg Officer) Option Ex 1,515 .00 0
2017-11-14 Ullian Elaine (Director) Option Ex 3,492 18.82 65,719
2017-11-13 Ullian Elaine (Director) Sale 9,282 40.50 375,921
2017-11-13 Ullian Elaine (Director) Option Ex 9,282 18.82 174,687
2017-11-08 Oberton Karleen Marie (Corp. VP & Chief Acctg Officer) Sale 1,256 39.29 49,348
2017-11-07 Bebo Allison P (SVP, Human Resources) Option Ex 14,048 .00 0
2017-11-07 Griffin John M. (General Counsel) Option Ex 38,014 .00 0
2017-11-07 Valenti Peter J. Iii (Division Pres., Breast Health) Option Ex 32,429 .00 0
2017-11-07 Mcmahon Robert W. (Chief Financial Officer) Option Ex 60,807 .00 0
2017-11-07 Compton Eric B. (COO) Option Ex 61,818 .00 0
2017-11-07 Oberton Karleen Marie (Corp. VP & Chief Acctg Officer) Option Ex 1,860 .00 0
2017-11-07 Macmillan Stephen P (Chairman, President and CEO) Option Ex 294,912 .00 0
2017-11-06 Oberton Karleen Marie (Corp. VP & Chief Acctg Officer) Sale 538 39.40 21,197
2017-11-05 Griffin John M. (General Counsel) Option Ex 2,502 .00 0
2017-11-05 West Thomas A. (Div President & GM, Diagnostic) Option Ex 2,085 .00 0
 1   2   3   4   5 

Insider trading activities including stock purchases, stock sales, and option exercises of HOLX listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Hologic Inc (symbol HOLX, CIK number 859737) see the Securities and Exchange Commission (SEC) website.



▪ Real-time Insider Trading

▪ Insider Officer Cluster Trading

▪ Top Officer Buys of the Week

▪ Top Officer Buys of the Month




©2023, insider-monitor.com. All rights reserved.